Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and D2 node dissection for gastric adenocarcinoma in INEN (Lima, Peru). Background: The global SPACE trial was conducted to evaluate ...

SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular ...

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality and one of the most commonly diagnosed cancers worldwide. 1 In the United States, the incidence of HCC has tripled ...

Combining transarterial chemoembolization (TACE) with lenvatinib (Lenvima) as first-line treatment for advanced hepatocellular carcinoma (HCC) prolonged survival compared with lenvatinib alone, the ...

The efficacy of transarterial techniques can be assessed in terms of imaging response (CT scan), biologic response (AFP), degree of tumor necrosis, patient survival or quality of life. The most ...

Please provide your email address to receive an email when new articles are posted on . Treatment with transarterial chemoembolization and Nexavar improved progression-free survival compared with ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival ...

Transarterial chemoembolization (TACE) can prevent tumor progression in patients with hepatocellular carcinoma (HCC) awaiting orthotropic liver transplantation (OLT); but the long-term outcome of ...

TACE/ADAM17 is a transmembranous protease that cleaves membrane-bound growth factors like EGFR ligands. TACE-dependent proteolysis is regulated by its inhibitor, tissue inhibitor of metalloproteinases ...

In this review we will discuss TACE, TAE and TOCE in detail. The TACE procedure consists of the injection of anticancer drugs mixed with or without lipiodol into the hepatic artery followed by the ...